Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1999 | 1 |
2000 | 1 |
2001 | 2 |
2002 | 1 |
2003 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Multiple myeloma.
Hematology Am Soc Hematol Educ Program. 2001:157-77. doi: 10.1182/asheducation-2001.1.157.
Hematology Am Soc Hematol Educ Program. 2001.
PMID: 11722983
Review.
Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines.
Shain KH, Landowski TH, Dalton WS.
Shain KH, et al.
J Immunol. 2002 Mar 1;168(5):2544-53. doi: 10.4049/jimmunol.168.5.2544.
J Immunol. 2002.
PMID: 11859150
Item in Clipboard
Alternative pathways of cell death to circumvent pleiotropic resistance in myeloma cells: role of cytotoxic T-lymphocytes.
Shtil AA, Turner JG, Dalton WS, Yu H.
Shtil AA, et al.
Leuk Lymphoma. 2000 Jun;38(1-2):59-70. doi: 10.3109/10428190009060319.
Leuk Lymphoma. 2000.
PMID: 10811448
Review.
Item in Clipboard
Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model.
Hazlehurst LA, Enkemann SA, Beam CA, Argilagos RF, Painter J, Shain KH, Saporta S, Boulware D, Moscinski L, Alsina M, Dalton WS.
Hazlehurst LA, et al.
Cancer Res. 2003 Nov 15;63(22):7900-6.
Cancer Res. 2003.
PMID: 14633719
Item in Clipboard
Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.
Nefedova Y, Landowski TH, Dalton WS.
Nefedova Y, et al.
Leukemia. 2003 Jun;17(6):1175-82. doi: 10.1038/sj.leu.2402924.
Leukemia. 2003.
PMID: 12764386
Item in Clipboard
Cytokine-based tumor cell vaccine is equally effective against parental and isogenic multidrug-resistant myeloma cells: the role of cytotoxic T lymphocytes.
Shtil AA, Turner JG, Durfee J, Dalton WS, Yu H.
Shtil AA, et al.
Blood. 1999 Mar 15;93(6):1831-7.
Blood. 1999.
PMID: 10068654
Free article.
Item in Clipboard
Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cells.
Oshiro MM, Landowski TH, Catlett-Falcone R, Hazlehurst LA, Huang M, Jove R, Dalton WS.
Oshiro MM, et al.
Clin Cancer Res. 2001 Dec;7(12):4262-71.
Clin Cancer Res. 2001.
PMID: 11751528
Item in Clipboard
Cite
Cite